(19)
(11) EP 2 496 256 A2

(12)

(88) Date of publication A3:
13.10.2011

(43) Date of publication:
12.09.2012 Bulletin 2012/37

(21) Application number: 10828938.0

(22) Date of filing: 29.10.2010
(51) International Patent Classification (IPC): 
A61K 39/275(2006.01)
C07K 1/10(2006.01)
 A61K 39/385(2006.01)
(86) International application number:
PCT/US2010/054668
(87) International publication number:
WO 2011/056721 (12.05.2011 Gazette 2011/19)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 05.11.2009 US 258369 P
06.11.2009 US 258729 P
05.04.2010 US 754140
06.04.2010 US 754740
30.08.2010 US 378059 P

(71) Applicant: CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY
Belleville, NJ 07109 (US)

(72) Inventors:
  • TAYLOR, Alice P.
    Morris Plains New Jersey 07950 (US)
  • MAKABI-PANZU, Boby
    Morris Plains New Jersey 07950 (US)
  • GOLDENBERG, David M.
    Morris Plains New Jersey 07950 (US)

(74) Representative: Bohmann, Armin K. 
Bohmann Anwaltssozietät Nymphenburger Straße 1
80335 München
80335 München (DE)

   


(54) IMMUNOCONJUGATES COMPRISING POXVIRUS-DERIVED PEPTIDES AND ANTIBODIES AGAINST ANTIGEN-PRESENTING CELLS FOR SUBUNIT-BASED POXVIRUS VACCINES